HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Breast Cancer Research and Treatment

Breast cancer research and treatment represent a dynamic and continually evolving field dedicated to understanding the complexities of breast cancer and developing innovative strategies for its diagnosis and management. Extensive research efforts focus on elucidating the molecular mechanisms underlying breast cancer development, progression, and metastasis. This involves studying genetic mutations, hormonal influences, and the tumor microenvironment to identify potential biomarkers that can aid in early detection and prognosis. Advances in genomic medicine have paved the way for personalized treatment approaches, tailoring interventions based on the specific genetic makeup of an individual's breast cancer.

The treatment landscape for breast cancer has witnessed significant progress, encompassing a range of modalities such as surgery, chemotherapy, radiation therapy, hormonal therapy, and targeted therapies. Clinical trials play a pivotal role in testing novel therapeutic agents and treatment strategies, contributing to the continuous refinement of breast cancer treatment protocols. Additionally, research in supportive care, survivorship, and quality of life aspects for breast cancer patients is integral to fostering comprehensive and patient-centered approaches. The collaborative efforts of researchers, clinicians, and advocacy groups underscore a commitment to advancing breast cancer research and treatment, aiming for improved outcomes and a better quality of life for individuals affected by this prevalent malignancy.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp